RxDoctor Payments DataLook up a doctor →

Ahmad Al-Hamda, MD

Neurology with Special Qualifications in Child Neurology · Muscle Shoals, ALNPI 1851357586

Payments from drug & device makers

$8,298in general payments, 2019–2025

Across 464 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$911
  • AstraZeneca$800
  • UCB, Inc.$439
  • Lundbeck LLC$377
  • Eisai Inc.$362
  • plus $4K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)85$1,128
Novartis53$911
AstraZeneca(2 entities)34$800
UCB, Inc.20$439
Lundbeck LLC18$377
Eisai Inc.20$362
EMD Serono, Inc.31$361
Sunovion Pharmaceuticals Inc.22$336
Teva Pharmaceuticals USA, Inc.22$327
Amgen(2 entities)17$324
SK Life Science, Inc.12$285
Akcea Therapeutics, Inc.3$175
Pfizer11$171
Biogen8$163
Genentech USA, Inc.10$162
Tanabe Pharma America, Inc.9$147
Amneal Pharmaceuticals LLC8$144
Lilly USA, LLC8$139
Livanova USA, Inc.2$138
Biohaven Pharmaceuticals, Inc.8$129
Argenx US, Inc.5$119
Biohaven Pharmaceutical Holding Company Ltd.6$111
Takeda Pharmaceuticals U.S.A., Inc.4$98
CSL Behring4$94
Banner Life Sciences, LLC4$72
Jazz Pharmaceuticals Inc.3$63
Sumitomo Pharma America, Inc.2$60
Supernus Pharmaceuticals, Inc.3$57
Upsher-smith Laboratories LLC3$51
Sanofi2$47
Shire North American Group Inc2$42
Boston Scientific2$40
Catalyst Pharmaceuticals, Inc.2$40
GE HealthCare2$38
E.r. Squibb & Sons, L.L.C.2$37
Johnson & Johnson1$36
Otsuka America Pharmaceutical, Inc.2$35
Axsome Therapeutics, Inc.1$32
Acorda Therapeutics, Inc1$23
MDD US Operations, LLC1$23
Neurelis, Inc.1$21
Grifols USA, LLC1$19
Ironshore Pharmaceuticals Inc.1$16
Arbor Pharmaceuticals, Inc.1$16
GSK1$15
Assertio Therapeutics, Inc.1$14
Scilex Pharmaceuticals Inc.1$13
Acadia Pharmaceuticals Inc1$13
Vertical Pharmaceuticals, LLC1$12
Harmony Biosciences LLC1$12
Abbott1$12

How this compares

$8,298 in reported general payments places this provider in the 50th percentile of 24 neurology with special qualifications in child neurology providers in Alabama.

See all neurology with special qualifications in child neurology providers in Alabama →

Medicare billing

Part B allowed, 2024
$124,428
Medicare patients
485
Services billed
4,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Muscle Shoals

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →